Manifesto on inhaled triple therapy in asthma: an Interasma (Global Asthma Association - GAA) document

Objective: The optimal use of drug combinations for the management of asthma is providing significant results. This has prompted Interasma (Global Asthma Association) to take a position on inhaled triple therapy in asthma.Methods: We performed an extensive literature research to clinical trials, meta-analyses, randomized controlled trials and systematic reviews.Results: Starting from an extensive literature review, Interasma executive committee discussed and approved this Manifesto, developed by Interasma scientific network (INES) members.Conclusions: The manifesto describes the evidence gathered to date and states, advocates, and proposes issues on inhaled corticosteroid (ICS) plus long-acting beta 2 agonist (LABA) and long-acting muscarinic antagonists (LAMA) with the aim of challenging assumptions, fostering commitment, and bringing about change.

Automated summary

The article discusses the significant results of optimal drug combination for asthma management and Interasma's position on inhaled triple therapy. Through extensive literature research, the authors advocate for further studies on the benefits of inhaled corticosteroid, long-acting beta 2 agonist, and long-acting muscarinic antagonist combinations.